-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acute Respiratory Distress Syndrome – ARDS in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acute Respiratory Distress Syndrome – ARDS in Rheumatoid Arthritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Respiratory Distress Syndrome – ARDS...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acute Respiratory Distress Syndrome – ARDS in Crohn’s Disease (Regional Enteritis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acute Respiratory Distress Syndrome – ARDS in Crohn's Disease (Regional Enteritis) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Respiratory Distress Syndrome...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acute Respiratory Distress Syndrome – ARDS in Lupus Nephritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acute Respiratory Distress Syndrome – ARDS in Lupus Nephritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Respiratory Distress Syndrome – ARDS...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acute Respiratory Distress Syndrome – ARDS in Primary Sclerosing Cholangitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acute Respiratory Distress Syndrome – ARDS in Primary Sclerosing Cholangitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Respiratory Distress Syndrome –...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acute Respiratory Distress Syndrome – ARDS in Autoimmune Hepatitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acute Respiratory Distress Syndrome – ARDS in Autoimmune Hepatitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Respiratory Distress Syndrome – ARDS...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Telisotuzumab Vedotin in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Telisotuzumab Vedotin in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Telisotuzumab Vedotin in Non-Small Cell Lung Cancer Drug...
-
Product Insights
NewOsteonecrosis – Drugs In Development, 2024
Empower your strategies with our Osteonecrosis – Drugs In Development, 2024 report and make more profitable business decisions. Osteonecrosis is bone death caused by poor blood supply to the area. It is most common in the hip and shoulder, but can affect other large joints such as knee, elbow, wrist, and ankle. Osteonecrosis can be caused by disease or a severe trauma, such as a break or dislocation, that affects the blood supply to the bone. There are no symptoms in...
-
Product Insights
NewOsteoporosis – Drugs In Development, 2024
Empower your strategies with our Osteoporosis – Drugs In Development, 2024 report and make more profitable business decisions. Osteoporosis, or thinning bones, makes bones weak and more likely to break. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Signs and symptoms include back pain, caused by a fractured or collapsed vertebra, loss of height over time, a stooped posture, and a bone fracture that occurs much more easily than...
-
Product Insights
NewAxial Spondyloarthritis – Drugs In Development, 2024
Empower your strategies with our Axial Spondyloarthritis – Drugs In Development, 2024 report and make more profitable business decisions. Axial spondylitis is a type of inflammatory arthritis involving the spine and/or sacroiliac joints. Axial spondylitis is strongly related to the presence of the HLA-B27 gene. A genetic test for HLA-B27 is available. The Axial Spondyloarthritis drugs in development market research report provide comprehensive information on the therapeutics under development for Axial Spondyloarthritis, complete with analysis by stage of development, drug target,...
-
Product Insights
NewAnkylosing Spondylitis (Bekhterev’s Disease) – Drugs In Development, 2024
Empower your strategies with our Ankylosing Spondylitis (Bekhterev's Disease) – Drugs In Development, 2024 report and make more profitable business decisions. Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine's bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture. The Ankylosing Spondylitis (Bekhterev's Disease) drugs...